37
https://pubmed.ncbi.nlm.nih.gov/38116160
The oral agent imeglimin improved plasma glucose levels in two patients with latent autoimmune diabetes of adults when added to their current medication.
“Imeglimin Oral Agent Improves Plasma Glucose Levels in Adults with Latent Autoimmune Diabetes”
